Gene replacement therapy in achromatopsia type 2;Genersatztherapie bei genetisch bedingter Zapfenblindheit

Klinische Monatsblatter fur Augenheilkunde

Volumn 231, Issue 3, 2014, Pages 232-240

  Muhlfriedel R ^a   Tanimoto, N ^a   Seeliger, M W ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

AAV mediated gene therapy; achromatopsia; CNGA3 channel protein; hereditary retinal diseases; non invasive diagnostic methods

Indexed keywords

CYCLIC GMP; CYCLIC NUCLEOTIDE GATED CHANNEL; CNGA3 PROTEIN, HUMAN; CNGA3 PROTEIN, MOUSE;

ADENO ASSOCIATED VIRUS; ARTICLE; COLOR BLINDNESS; DIAGNOSTIC PROCEDURE; ELECTRORETINOGRAM; GENE MUTATION; GENE REPLACEMENT THERAPY; GERMANY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; SIGNAL TRANSDUCTION; ANIMAL; COLOR VISION DEFECTS; EVIDENCE BASED MEDICINE; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; MOUSE; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; COLOR VISION DEFECTS; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; EVIDENCE-BASED MEDICINE; GENETIC THERAPY; HUMANS; MICE; TRANSFECTION; TREATMENT OUTCOME;

EID: 84897006813     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0034-1368180     Document Type: Article

References (89)

1. Sohocki M. M., Daiger S. P., Bowne S. J. et al. Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat: 2001; 17 42 51 (Pubitemid 32054366)
2. Rattner A., Sun H., Nathans J. Molecular genetics of human retinal disease. Annu Rev Genet: 1999; 33 89 131 (Pubitemid 30083120)
3. Berger W., Kloeckener-Gruissem B., Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res: 2010; 29 335 375
4. Surace E. M., Auricchio A. Versatility of AAV vectors for retinal gene transfer. Vision Res: 2008; 48 353 359 (Pubitemid 351179513)
5. Thiadens A. A., Phan T. M., Zekveld-Vroon R. C. et al. Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy. Ophthalmology: 2012; 119 819 826
6. Francois J. Heredity in Ophthalmology. CV Mosby St Louis: 1961
7. Sharpe L. T., Nordby K. Total Colour Blindness: An Introduction. In: Hess R. F., Sharpe L. T., Nordby K. eds. Night Vision: basic, clinical and applied Aspects. Cambridge, UK Cambridge University Press: 1990; 253 289
8. Sharpe L. T., Stockman A., Jägle H. et al. Opsin Genes, Cone Photopigments and Colour Blindness. In: Gegenfurtner K. R., Sharpe L. T. eds. Color Vision: From Genes to Perception. Cambridge, UK Cambridge University Press: 1999
9. Park W. L., Sunness J. S. Red contact lenses for alleviation of photophobia in patients with cone disorders. Am J Ophthalmol: 2004; 137 774 775 (Pubitemid 38446706)
10. Schornack M. Prescription and management of contact lenses in patients with monocular visual impairment. Optometry: 2007; 78 652 656
11. Young R. S., Krefman R. A., Fishman G. A. Visual improvements with red-tinted glasses in a patient with cone dystrophy. Arch Ophthalmol: 1982; 100 268 271 (Pubitemid 12162234)
12. Kohl S., Baumann B., Rosenberg T. et al. Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am J Hum Genet: 2002; 71 422 425 (Pubitemid 34800258)
13. Aligianis I. A., Forshew T., Johnson S. et al. Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J Med Genet: 2002; 39 656 660 (Pubitemid 35001718)
14. Rosenberg T., Baumann B., Kohl S. et al. Variant phenotypes of incomplete achromatopsia in two cousins with GNAT2 gene mutations. Invest Ophthalmol Vis Sci: 2004; 45 4256 4262 (Pubitemid 39564647)
15. Ouechtati F., Merdassi A., Bouyacoub Y. et al. Clinical and genetic investigation of a large Tunisian family with complete achromatopsia: identification of a new nonsense mutation in GNAT2 gene. J Hum Genet: 2011; 56 22 28
16. Chang B., Grau T., Dangel S. et al. A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene. Proc Natl Acad Sci U S A: 2009; 106 19581 19586
17. Thiadens A. A., den Hollander A. I., Roosing S. et al. Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders. Am J Hum Genet: 2009; 85 240 247
18. Kohl S., Coppieters F., Meire F. et al. A nonsense mutation in PDE6H causes autosomal-recessive incomplete achromatopsia. Am J Hum Genet: 2012; 91 527 532
19. Wissinger B., Gamer D., Jägle H. et al. CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet: 2001; 69 722 737 (Pubitemid 32868518)
20. Kohl S., Marx T., Giddings I. et al. Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet: 1998; 19 257 259 (Pubitemid 28309337)
21. Sundin O. H., Yang J. M., Li Y. et al. Genetic basis of total colourblindness among the Pingelapese islanders. Nat Genet: 2000; 25 289 293 (Pubitemid 30437314)
22. Winick J. D., Blundell M. L., Galke B. L. et al. Homozygosity mapping of the Achromatopsia locus in the Pingelapese. Am J Hum Genet: 1999; 64 1679 1685 (Pubitemid 30481520)
23. Milunsky A., Huang X. L., Milunsky J. et al. A locus for autosomal recessive achromatopsia on human chromosome 8q. Clin Genet: 1999; 56 82 85 (Pubitemid 29354016)
24. Grau T., Artemyev N. O., Rosenberg T. et al. Decreased catalytic activity and altered activation properties of PDE6C mutants associated with autosomal recessive achromatopsia. Hum Mol Genet: 2011; 20 719 730
25. Kohl S., Varsanyi B., Antunes G. A. et al. CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet: 2005; 13 302 308 (Pubitemid 40360784)
26. Michaelides M., Aligianis I. A., Ainsworth J. R. et al. Progressive cone dystrophy associated with mutation in CNGB3. Invest Ophthalmol Vis Sci: 2004; 45 1975 1982 (Pubitemid 38868997)
27. Thiadens A. A., Slingerland N. W., Roosing S. et al. Genetic etiology and clinical consequences of complete and incomplete achromatopsia. Ophthalmology: 2009; 116 1984 1989
28. Kohl S., Kitiratschky V., Papke M. et al. Genes and mutations in autosomal dominant cone and cone-rod dystrophy. Adv Exp Med Biol: 2012; 723 337 343
29. Johnson S., Michaelides M., Aligianis I. A. et al. Achromatopsia caused by novel mutations in both CNGA3 and CNGB3. J Med Genet: 2004; 41 e20
30. Kaupp U. B., Seifert R. Cyclic nucleotide-gated ion channels. Physiol Rev: 2002; 82 769 824 (Pubitemid 34743338)
31. Zhong H., Molday L. L., Molday R. S. et al. The heteromeric cyclic nucleotide-gated channel adopts a 3A:1B stoichiometry. Nature: 2002; 420 193 198 (Pubitemid 35340125)
32. Zagotta W. N., Siegelbaum S. A. Structure and function of cyclic nucleotide-gated channels. Annu Rev Neurosci: 1996; 19 235 263 (Pubitemid 26080829)
33. Hofmann F., Biel M., Kaupp U. B. et al. International Union of Pharmacology. XLII. Compendium of voltage-gated ion channels: cyclic nucleotide-modulated channels. Pharmacol Rev: 2003; 55 587 589 (Pubitemid 37500519)
34. Hofmann F., Biel M., Kaupp U. B. International Union of Pharmacology. LI. Nomenclature and structure-function relationships of cyclic nucleotide-regulated channels. Pharmacol Rev: 2005; 57 455 462 (Pubitemid 43036435)
35. Ali R. R., Reichel M. B., Thrasher A. J. et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet: 1996; 5 591 594 (Pubitemid 26141271)
36. Allocca M., Mussolino C., Garcia-Hoyos M. et al. Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J Virol: 2007; 81 11372 11380 (Pubitemid 47536108)
37. Bainbridge J. W., Mistry A., Schlichtenbrede F. C. et al. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina. Gene Ther: 2003; 10 1336 1344 (Pubitemid 36987124)
38. Buch P. K., Bainbridge J. W., Ali R. R. AAV-mediated gene therapy for retinal disorders: from mouse to man. Gene Ther: 2008; 15 849 857 (Pubitemid 351712618)
39. Pang J. J., Lauramore A., Deng W. T. et al. Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration. Vision Res: 2008; 48 377 385 (Pubitemid 351179516)
40. Chen J., Tucker C. L., Woodford B. et al. The human blue opsin promoter directs transgene expression in short-wave cones and bipolar cells in the mouse retina. Proc Natl Acad Sci U S A: 1994; 91 2611 2615 (Pubitemid 24139397)
41. Yang G. S., Schmidt M., Yan Z. et al. Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J Virol: 2002; 76 7651 7660 (Pubitemid 34760989)
42. Glushakova L. G., Timmers A. M., Pang J. et al. Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors. Invest Ophthalmol Vis Sci: 2006; 47 3505 3513 (Pubitemid 351639717)
43. Komáromy A. M., Alexander J. J., Cooper A. E. et al. Targeting gene expression to cones with human cone opsin promoters in recombinant AAV. Gene Ther: 2008; 15 1049 1055 Erratum in: Gene Ther 2008; 15: 1073; Glushakova LG [added]. Gene Ther 2011; 18: 1179 (Pubitemid 351927695)
44. Lebherz C., Maguire A., Tang W. et al. Novel AAV serotypes for improved ocular gene transfer. J Gene Med: 2008; 10 375 382 (Pubitemid 351517093)
45. Smith R. H. Adeno-associated virus integration: virus versus vector. Gene Therapy: 2008; 15 817 822 (Pubitemid 351712614)
46. Schnepp B. C., Jensen R. L., Chen C. L. et al. Characterization of adeno-associated virus genomes isolated from human tissues. J Virol: 2005; 79 14793 14803 (Pubitemid 41636277)
47. Grieger J. C., Samulski R. J. Adeno-associated virus vectorology, manufacturing, and clinical applications. Methods Enzymol: 2012; 507 229 254
48. Surace E. M., Auricchio A. Versatility of AAV vectors for retinal gene transfer. Vision Res: 2008; 48 353 359 (Pubitemid 351179513)
49. Petrs-Silva H., Dinculescu A., Li Q. et al. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther: 2009; 17 463 471
50. Allocca M., Doria M., Petrillo M. et al. Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest: 2008; 118 1955 1964 (Pubitemid 351632397)
51. Acland G. M., Aguirre G. D., Ray J. et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet: 2001; 28 92 95 (Pubitemid 32405824)
52. Ali R. R., Sarra G. M., Stephens C. et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet: 2000; 25 306 310 (Pubitemid 30437318)
53. Bainbridge J. W., Smith A. J., Barker S. S. et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med: 2008; 358 2231 2239 (Pubitemid 351724452)
54. Cideciyan A. V., Aleman T. S., Boye S. L. et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A: 2008; 105 15112 15117
55. Hauswirth W. W., Aleman T. S., Kaushal S. et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther: 2008; 19 979 990
56. Timmers A. M., Zhang H., Squitieri A. et al. Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina. Mol Vis: 2001; 7 131 137 (Pubitemid 36153662)
57. Johnson C. J., Berglin L., Chrenek M. A. et al. Technical brief: subretinal injection and electroporation into adult mouse eyes. Mol Vis: 2008; 14 2211 2226
58. Busskamp V., Duebel J., Balya D. et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science: 2010; 329 413 417
59. Price J., Turner D., Cepko C. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A: 1987; 84 156 160 (Pubitemid 17013593)
60. Schlichtenbrede F. C., da Cruz L., Stephens C. et al. Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. J Gene Med: 2003; 5 757 764 (Pubitemid 40309713)
61. Mühlfriedel R., Michalakis S., Garrido M. G. et al. Optimized technique for subretinal injections in mice. Methods Mol Biol: 2013; 935 343 349
62. Liang F. Q., Anand V., Maguire A. M. et al. Intraocular delivery of recombinant virus. Methods Mol Med: 2001; 47 125 139
63. Seeliger M. W., Beck S. C., Pereyra-Muñoz N. et al. In vivo confocal imaging of the retina in animal models using scanning laser ophthalmoscopy. Vision Res: 2005; 45 3512 3519 (Pubitemid 41737379)
64. Huber G., Beck S. C., Grimm C. et al. Spectral domain optical coherence tomography in mouse models of retinal degeneration. Invest Ophthalmol Vis Sci: 2009; 50 5888 5895
65. Fischer M. D., Huber G., Beck S. C. et al. Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography. PLoS One: 2009; 4 e7507
66. Marmor M. F., Fulton A. B., Holder G. E. et al. International Society for Clinical Electrophysiology of Vision MISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol: 2009; 118 69 77
67. Scholl H. P., Zrenner E. Electrophysiology in the investigation of acquired retinal disorders. Surv Ophthalmol: 2000; 45 29 47 (Pubitemid 30628687)
68. Dalke C., Löster J., Fuchs H. et al. Electroretinography as a screening method for mutations causing retinal dysfunction in mice. Invest Ophthalmol Vis Sci: 2004; 45 601 609 (Pubitemid 38140520)
69. Tanimoto N., Muehlfriedel R. L., Fischer M. D. et al. Vision tests in the mouse: Functional phenotyping with electroretinography. Front Biosci (Landmark Ed): 2009; 14 2730 2737
70. Douglas R. M., Alam N. M., Silver B. D. et al. Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system. Vis Neurosci: 2005; 22 677 684 (Pubitemid 43237762)
71. Umino Y., Solessio E., Barlow R. B. Speed, spatial, and temporal tuning of rod and cone vision in mouse. J Neurosci: 2008; 28 189 198
72. Alexander J. J., Umino Y., Everhart D. et al. Restoration of cone vision in a mouse model of achromatopsia. Nat Med: 2007; 13 685 687 (Pubitemid 46889758)
73. Deeb S. S. Molecular genetics of color-vision deficiencies. Vis Neurosci: 2004; 21 191 196 (Pubitemid 39481955)
74. Wiszniewski W., Lewis R. A., Lupski J. R. Achromatopsia: the CNGB3 p.T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14. Hum Genet: 2007; 121 433 439 (Pubitemid 46554679)
75. Carvalho L. S., Xu J., Pearson R. A. et al. Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet: 2011; 20 3161 3175
76. Aguirre G. D., Rubin L. F. Pathology of hemeralopia in the Alaskan malamute dog. Invest Ophthalmol: 1974; 13 231 235
77. Aguirre G. D., Rubin L. F. The electroretinogram in dogs with inherited cone degeneration. Invest Ophthalmol: 1975; 14 840 847
78. Rubin L. F. Clinical features of hemeralopia in the adult Alaskan malamute. J Am Vet Med Assoc: 1971; 158 1696 1698
79. Sidjanin D. J., Lowe J. K., McElwee J. L. et al. Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet: 2002; 11 1823 1833
80. Komáromy A. M., Alexander J. J., Rowlan J. S. et al. Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet: 2010; 19 2581 2593 Erratum in: Hum Mol Genet 2011; 20: 5024
81. Michalakis S., Mühlfriedel R., Tanimoto N. et al. Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. Mol Ther: 2010; 18 2057 2063
82. Biel M., Seeliger M., Pfeifer A. et al. Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3. Proc Natl Acad Sci U S A: 1999; 96 7553 7557 (Pubitemid 29299700)
83. Michalakis S., Geiger H., Haverkamp S. et al. Impaired opsin targeting and cone photoreceptor migration in the retina of mice lacking the cyclic nucleotide-gated channel CNGA3. Invest Ophthalmol Vis Sci: 2005; 46 1516 1524 (Pubitemid 41685898)
84. Hawes N. L., Wang X., Hurd R. E. A point mutation in the Cnga3 gene causes cone photoreceptor function loss (Cpfl5) in mice. Paper presented at ARVO, E-Abstract 4579: 2006, Fort Lauderdale. 2006
85. Pang J. J., Deng W. T., Dai X. et al. AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia. PLoS One: 2012; 7 e35250
86. Maguire A. M., Simonelli F., Pierce E. A. et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med: 2008; 358 2240 2248 (Pubitemid 351724453)
87. Amado D., Mingozzi F., Hui D. et al. Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness. Sci Transl Med: 2010; 2 21ra16
88. Jacobson S. G., Cideciyan A. V., Ratnakaram R. et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol: 2012; 130 9 24
89. Zhang S., Wu J., Wu X. et al. Enhancement of rAAV2-mediated transgene expression in retina cells in vitro and in vivo by coadministration of low-dose chemotherapeutic drugs. Invest Ophthalmol Vis Sci: 2012; 53 2675 2684